Home  >  News
Msc_Apr23 Advertisement
you can get e-magazine links on WhatsApp. Click here
Biotechnology + Font Resize -

Oramed Pharma forms JV, Oravax Medical to develop new oral Covid-19 vaccines

New York
Monday, March 22, 2021, 12:00 Hrs  [IST]

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that it has entered into definitive agreements to form a joint venture focused on the development of novel oral Covid-19 vaccines.  The new company, Oravax Medical Inc., is based on Oramed’s proprietary POD oral delivery technology and Premas Biotech Pvt Ltd’s novel vaccine technology.

Oravax’s Covid-19 vaccine candidate benefits from being a virus like particle (VLP) triple antigen vaccine that targets three structural proteins, which should make it a better candidate for protection across emerging mutations of the coronavirus.  The oral delivery of the vaccine should allow for widescale inoculation and easier distribution of the vaccine without requiring an injection.

In a pilot animal study, the oral Covid-19 vaccine promoted both systemic immunity through Immunoglobulin G (IgG), the most common antibody in blood and bodily fluids that protects against viral infections, and Immunoglobulin A (IgA).

Oravax anticipates commencing a clinical study during the second quarter of 2021.

“An oral Covid-19 vaccine would eliminate several barriers to rapid, widescale distribution, potentially enabling people to take the vaccine themselves at home. While ease of administration is critical today to accelerate inoculation rates, an oral vaccine could become even more valuable in the case that a Covid-19 vaccine may be recommended annually like the standard flu shot,” said Nadav Kidron, CEO of Oramed.

Oravax was established in 2021 by Oramed Pharmaceuticals Inc., the largest shareholder in Oravax, along with Premas Biotech and certain other shareholders with a mission to bring an oral Covid-19 vaccine to the market.  

Oramed Pharmaceuticals is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection.


* Name :     
* Email :    
  Website :  
Copyright © 2016 Saffron Media Pvt. Ltd |